Applied Therapeutics Inc (APLT)
$5.22
+0.02
(+0.38%)▲
Performance
- $5.16$5.31$5.22
1.25%
Downside
Day's Volatility :2.92%
Upside
1.69%
- $1.18$9.39$5.22
77.39%
Downside
52 Weeks Volatility :87.43%
Upside
44.41%
Returns
| Period | Applied Therapeutics Inc | Sector (Health Care) | Index (Russel 2000) |
|---|---|---|---|
3 Months | 21.5% | 6.5% | 0.0% |
6 Months | 78.69% | 7.1% | 0.0% |
1 Year | 242.11% | 9.8% | 0.0% |
3 Years | -71.43% | 14.2% | -20.2% |
Highlights
Market Capitalization | 598.8M |
Book Value | $0.59 |
Earnings Per Share (EPS) | -1.91 |
Wall Street Target Price | 11.4 |
Profit Margin | 0.0% |
Operating Margin TTM | -11101.58% |
Return On Assets TTM | -51.57% |
Return On Equity TTM | -612.33% |
Revenue TTM | -477.0K |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | -98.2% |
Gross Profit TTM | 0.0 |
EBITDA | -74.8M |
Diluted Eps TTM | -1.91 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -1.17 |
EPS Estimate Next Year | -0.46 |
EPS Estimate Current Quarter | -0.16 |
EPS Estimate Next Quarter | -0.18 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 118.39%
Technicals Summary
Sell
Neutral
Buy
Applied Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Applied Therapeutics Inc | 16.59% | 78.69% | 242.11% | -71.43% | -74.79% |
 Moderna, Inc. | -1.67% | 18.26% | -0.21% | -64.15% | 752.69% |
 Regeneron Pharmaceuticals, Inc. | -0.46% | 13.21% | 45.59% | 84.19% | 244.2% |
 Novo Nordisk A/s | -11.0% | 18.31% | 61.56% | 186.46% | 423.59% |
 Vertex Pharmaceuticals Incorporated | 3.85% | 14.43% | 39.88% | 147.45% | 195.07% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Applied Therapeutics Inc | NA | NA | NA | -1.17 | -6.12 | -0.52 | NA | 0.59 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.19 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 31.35 | 31.35 | 1.46 | 44.44 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 44.28 | 44.28 | 2.36 | 3.43 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 31.85 | 31.85 | 0.53 | 16.98 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Applied Therapeutics Inc | Buy | $598.8M | -74.79% | NA | 0.0% |
Moderna, Inc. | Buy | $45.3B | 752.69% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $116.9B | 244.2% | 31.35 | 29.45% |
Novo Nordisk A/s | Buy | $572.0B | 423.59% | 44.28 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $126.7B | 195.07% | 31.85 | 39.46% |
Insights on Applied Therapeutics Inc
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 186.5% return, outperforming this stock by 257.9%
Institutional Holdings
Franklin Resources Inc
9.25%VR Adviser, LLC
7.94%Perceptive Advisors LLC
7.01%HHG PLC
5.61%Propel Bio Management LLC
5.35%Knoll Capital Management LP
4.88%
Company Information
applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.
Organization | Applied Therapeutics Inc |
Employees | 26 |
CEO | Dr. Shoshana Shendelman Ph.D. |
Industry | Biotechnology |
Discover More
A Spac I Acquisition Corp
$5.22
+0.38%
Keyarch Acquisition Corp
$5.22
+0.38%
Connexa Sports Technologies Inc
$5.22
+0.38%
Us Value Etf
$5.22
+0.38%
First Wave Biopharma Inc
$5.22
+0.38%
Global X Msci Next Emerging
$5.22
+0.38%
Fat Projects Acquisition Corp
$5.22
+0.38%
Capital Link Global Fintech
$5.22
+0.38%
Applied Uv Inc
$5.22
+0.38%